NEW YORK (GenomeWeb News) – NanoString Technologies today said that it anticipates raising as much as $77.6 million in its initial public offering.

In its amended Form S-1 filed with the US Securities and Exchange Commission, the company said it expects to offer 5.4 million shares of its common stock at a price range of $13 to $15 per share. Based on the midpoint price of $14, net proceeds from the offering would be about $67 million, or $77.6 million, if the underwriters exercise their overallotment option in full.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Though many details have yet to be worked out, the draft deal for the UK's withdrawal from the EU is giving researchers some hints for what they can expect, Nature News says.

DNA testing has solved a 100-year-old mystery contained in the skull and teeth samples of a now-extinct monkey that once inhabited Jamaica, Gizmodo reports.

As the UN ponders a ban on gene drives, one malaria researcher says there are less dramatic ways to fight the disease in Africa than unleashing GM mosquitoes on a whole continent.

In Nature this week: an improved reference genome of the Aedes aegypti mosquito, genomes of four species of truffles, and more.